Humana Inc vs Mondaycom Ltd — how do they compare? Humana Inc trades at $445 (market cap $46.49B), while Mondaycom Ltd trades at $88.8 (market cap $3.76B). The key difference: Humana Inc is far larger — about 12.4× Mondaycom Ltd's market cap, and Humana Inc pays a 0.91% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Mondaycom Ltd for 16 Days on average.
| HUM | MNDY | |
|---|---|---|
Market Cap | $46.49B | $3.76B |
Volume | 2,567,704 | 836,200 |
Sector | Health | Technology |
52-Week High | $409.85 | $205.24 |
52-Week Low | $163.67 | $58.81 |
Typical Hold Time | 53 Days | 16 Days |
Enterprise Value | $53.84B | $2.92B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
MNDY trades at $83.51, down 0.93% on the day, with technical indicators showing a bearish trend despite recent earnings beats. The company maintains strong profitability with 88.74% gross margins and has exceeded EPS expectations for three consecutive quarters. Recent news highlights inclusion in growth stock lists and positive analyst sentiment, while the upcoming Q3 2026 earnings report (expected EPS $1.37) will be a key catalyst.
The outlook remains positive with 65% analyst buy ratings and a $110.42 consensus price target suggesting 32% upside potential. Risks include elevated valuation multiples (P/E 37.69), competitive pressures from enterprise software rivals, and the technical bearish signal. Strong enterprise customer growth and AI integration through the Elevate '26 conference provide growth catalysts.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →